Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines
Clinical trial NCT01367158 · COMPLETED
Trial details
- NCT number
- NCT01367158
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-01-01
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.